Herbalife Nutrition Ltd. shares dropped sharply in morning trading, falling 12.7% after the company disclosed a planned departure at the CEO level and a temporary leadership handoff. The announcement said Chief Executive Officer Stephan Gratziani will exit the role effective October 31, 2026. Chief Financial Officer John DeSimone will assume duties as Interim CEO beginning November 1, 2026 while the Board’s newly formed succession committee conducts a search for a permanent successor.
The company noted that Gratziani - who joined Herbalife in 2023 as Chief Strategy Officer and later became CEO - will remain connected to the business in a consulting capacity focused on strategy and business development. The filing also states Gratziani will redirect attention to his independent distributorship network, which the company describes as nearly 700,000 distributors and preferred members.
Alongside the leadership update, Herbalife reaffirmed the financial outlook it issued on August 5, 2026. The guidance calls for Q3 reported net sales to grow between 0.5% and 4.5% year-over-year and projects adjusted EBITDA of $160 million to $180 million for the quarter. While the reaffirmation preserves the near-term numerical outlook, the market response suggests investors were not reassured by the stability of the executive team.
Investor concern was compounded by recent insider activity. Over the past twelve months, insiders have sold roughly thirteen times more in share value than they have purchased, a dynamic market participants often view as a negative signal about confidence in the company’s near-term prospects.
Market context intensified pressure on Herbalife’s stock. Major U.S. equity benchmarks were lower on the session - the S&P 500 down about 0.4%, the Dow Jones Industrial Average down roughly 0.7%, and the Nasdaq off near 0.4% - as geopolitical tensions in the Persian Gulf following U.S. military strikes on Iranian positions pushed oil prices higher. Those moves heightened inflation concerns and reinforced expectations of a more hawkish Federal Reserve stance, creating a risk-off environment less tolerant of company-specific uncertainty.
Within that backdrop, HLF hit a session low of $10.41, well below the prior close of $12.43, and was trading near the lower portion of its 52-week range of $7.56 to $20.40. The combination of an abrupt CEO exit, an open-ended timeline for naming a permanent leader, and adverse macroeconomic signals contributed to the steep intraday drop and underscored investor sensitivity to perceived strategic instability.
Summary takeaways:
- Herbalife announced an October 31, 2026 CEO departure and an interim appointment effective November 1, 2026.
- The company maintained its previously issued Q3 and full-year 2026 guidance.
- Heightened insider selling and a fragile market environment amid rising oil prices amplified the stock's decline.